Similar articles

• Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.

  Moss AJ. Moss AJ. Cardiol J. 2013;20(3):217-9. doi: 10.5603/CJ.2013.0064. Cardiol J. 2013. PMID: 23788293 No abstract available.
• [Indication of implantable cardioverter defibrillator for heart failure].

  Noda T, Kamakura S. Noda T, et al. Nihon Rinsho. 2007 May 28;65 Suppl 5:195-9. Nihon Rinsho. 2007. PMID: 17571384 Review. Japanese. No abstract available.
• Implantable cardioverter-defibrillator lead failure: how weak is the link?

  Brinker JA. Brinker JA. Nat Clin Pract Cardiovasc Med. 2008 Dec;5(12):758-9. doi: 10.1038/ncpcardio1367. Epub 2008 Oct 7. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18838965
• [Cardiac resynchronization therapy-always with ICD?].

  Stellbrink C. Stellbrink C. Herz. 2005 Nov;30(7):596-600. doi: 10.1007/s00059-005-2762-x. Herz. 2005. PMID: 16333584 German.
• The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.

  Thakor NV, Natarajan A. Thakor NV, et al. Med Des Mater. 1991 Mar;1(3):16-24. Med Des Mater. 1991. PMID: 10147992 Review.